Publications by authors named "Yin-Hua Gong"
Article Synopsis
- - The standard treatment for small-cell lung cancer (SCLC) is platinum-based chemotherapy, which has a high response rate of 50-90%.
- - Durvalumab, an immune checkpoint inhibitor, is now recommended as a first-line treatment alongside traditional chemotherapy for advanced SCLC, although it can lead to immune-related side effects.
- - This case report highlights a man in his late 50s with extensive-stage SCLC who developed rare and potentially fatal autoimmune encephalitis after receiving durvalumab treatment, contributing to the understanding of this adverse effect.
Vinca alkaloid (VA)-induced ileus, a rare but severe autonomic neuropathy, can be enhanced by concomitant use of antifungal triazole agents. We herein present a case of VA-induced ileus in a 17-year-old girl who was diagnosed with B-cell acute lymphoblastic leukemia. On day 1, the patient received cyclophosphamide, vincristine, and methylprednisolone.
View Article and Find Full Text PDF